Panion & Bf Biotech (TPE:1760) Total Stockholders Equity : NT$1,832 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Panion & Bf Biotech Total Stockholders Equity?

Panion & Bf Biotech's Total Stockholders Equity for the quarter that ended in Mar. 2024 was NT$1,832 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Panion & Bf Biotech's Book Value per Share for the quarter that ended in Mar. 2024 was NT$21.36. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Panion & Bf Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.37.

Panion & Bf Biotech Total Stockholders Equity Historical Data

The historical data trend for Panion & Bf Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panion & Bf Biotech Total Stockholders Equity Chart

Panion & Bf Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,359.57

1,239.97

1,933.01

2,007.11

1,911.08

Panion & Bf Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															1,857.97	1,873.53	1,888.51	1,911.08	1,831.68

Panion & Bf Biotech (TPE:1760) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Panion & Bf Biotech's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1831.676	-	0)	/	85.739
	=	21.36

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Panion & Bf Biotech's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(549.807	+	136.494)	/	1831.676
	=	0.37

Panion & Bf Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Panion & Bf Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Panion & Bf Biotech (TPE:1760) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panion & Bf Biotech Inc (TPE:1760) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 16th Floor, F Building, Nangang District, Taipei, TWN, 11503

Website

https://www.pbf.com.tw

Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. It is engaged in research and development of pharmaceuticals and new drugs. It focuses on pharmaceuticals, cosmeceuticals, nutraceuticals, and medical devices sectors. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generate majority of the revenue from Taiwan segment.

Panion & Bf Biotech (TPE:1760) Headlines

No Headlines